- Home
- JZ vs PYPD Comparison
JZ vs PYPD Comparison
Compare JZ & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- PYPD
- Stock Information
- Founded
- JZ 2011
- PYPD 2008
- Country
- JZ China
- PYPD Israel
- Employees
- JZ N/A
- PYPD N/A
- Industry
- JZ Other Consumer Services
- PYPD Medical/Dental Instruments
- Sector
- JZ Real Estate
- PYPD Health Care
- Exchange
- JZ Nasdaq
- PYPD Nasdaq
- Market Cap
- JZ 26.7M
- PYPD 30.1M
- IPO Year
- JZ 2022
- PYPD 2020
- Fundamental
- Price
- JZ $0.83
- PYPD $2.71
- Analyst Decision
- JZ
- PYPD Strong Buy
- Analyst Count
- JZ 0
- PYPD 2
- Target Price
- JZ N/A
- PYPD $10.50
- AVG Volume (30 Days)
- JZ 4.1K
- PYPD 12.4K
- Earning Date
- JZ 01-01-0001
- PYPD 05-07-2025
- Dividend Yield
- JZ N/A
- PYPD N/A
- EPS Growth
- JZ N/A
- PYPD N/A
- EPS
- JZ N/A
- PYPD N/A
- Revenue
- JZ $50,810,288.00
- PYPD N/A
- Revenue This Year
- JZ N/A
- PYPD N/A
- Revenue Next Year
- JZ N/A
- PYPD N/A
- P/E Ratio
- JZ N/A
- PYPD N/A
- Revenue Growth
- JZ N/A
- PYPD N/A
- 52 Week Low
- JZ $0.53
- PYPD $2.37
- 52 Week High
- JZ $2.35
- PYPD $5.09
- Technical
- Relative Strength Index (RSI)
- JZ 45.93
- PYPD 42.57
- Support Level
- JZ $0.75
- PYPD $2.66
- Resistance Level
- JZ $0.92
- PYPD $2.75
- Average True Range (ATR)
- JZ 0.07
- PYPD 0.12
- MACD
- JZ -0.02
- PYPD -0.01
- Stochastic Oscillator
- JZ 32.20
- PYPD 11.48
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.